XML 34 R19.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Stock Option Plan and Stock Based Compensation | 12 Months Ended
--- | ---
Feb. 28, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock Option Plan and Stock Based Compensation | (11) Stock Option Plan and Stock Based Compensation The Company grants stock options and restricted stock to key executives and managerial employees and non-employee directors. At fiscal year ended 2017, the Company has one stock option plan: the 2004 Long-Term Incentive Plan of Ennis, Inc., as amended and restated as of June 30, 2011, formerly the 1998 Option and Restricted Stock Plan amended and restated as of May 14, 2008 (the “Plan”). The Company has 604,308 shares of unissued common stock reserved under the plan for issuance. The exercise price of each stock option granted under the Plan equals a referenced price of the Company’s common stock as reported on the New York Stock Exchange on the date of grant, and an option’s maximum term is ten years. Stock options and restricted stock may be granted at different times during the year and vest ratably over various periods, from grant date up to five years. The Company uses treasury stock to satisfy option exercises and restricted stock awards. The Company recognizes compensation expense for stock options and restricted stock grants on a straight-line basis over the requisite service period. For the years ended 2017, 2016 and 2015, the Company included in selling, general and administrative expenses, compensation expense related to share based compensation of $1.4 million ($0.9 million net of tax), $1.3 million ($0.8 million net of tax) and $1.3 million ($0.8 million net of tax), respectively. Stock Options The Company had the following stock option activity for the three years ended February 28, 2017:
|  | Number of Shares (exact quantity) |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Life (in years) |  |  | Aggregate Intrinsic Value(a) (in thousands) |
Outstanding at March 1, 2014 |  |  | 369,405 |  |  | $ | 15.86 |  |  |  | 6.0 |  |  | $ | 416 |
Granted |  |  | 31,418 |  |  |  | 15.78 |  |  |  |  |  |  |  |  |
Terminated |  |  | (20,000 | ) |  |  | 16.21 |  |  |  |  |  |  |  |  |
Exercised |  |  | (6,000 | ) |  |  | 8.94 |  |  |  |  |  |  |  |  |
Outstanding at February 28, 2015 |  |  | 374,823 |  |  | $ | 15.95 |  |  |  | 5.7 |  |  | $ | 210 |
Granted |  |  | 43,426 |  |  |  | 13.69 |  |  |  |  |  |  |  |  |
Terminated |  |  | (47,300 | ) |  |  | 18.31 |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Outstanding at February 29, 2016 |  |  | 370,949 |  |  | $ | 15.38 |  |  |  | 5.9 |  |  | $ | 1,616 |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Terminated |  |  | (5,000 | ) |  |  | 8.94 |  |  |  |  |  |  |  |  |
Exercised |  |  | (193,453 | ) |  |  | 15.04 |  |  |  |  |  |  |  |  |
Outstanding at February 28, 2017 |  |  | 172,496 |  |  | $ | 15.95 |  |  |  | 4.2 |  |  | $ | 223 |
Exercisable at February 28, 2017 |  |  | 167,423 |  |  | $ | 16.00 |  |  |  | 4.1 |  |  | $ | 213 |
(a) | Intrinsic value is measured as the excess fair market value of the Company’s Common Stock as reported on the New York Stock Exchange over the applicable exercise price.
No stock options were granted during fiscal year 2017. The following is a summary of the assumptions used and the weighted average grant-date fair value of the stock options granted during fiscal years 2016 and 2015:
|  | 2016 |  |  | 2015 |
Expected volatility |  |  | 24.06 | % |  |  | 29.25 | %
Expected term (years) |  |  | 3 |  |  |  | 3 |
Risk free interest rate |  |  | 0.89 | % |  |  | 0.91 | %
Dividend yield |  |  | 4.92 | % |  |  | 4.11 | %
Weighted average grant-date fair value |  | $ | 2.24 |  |  | $ | 2.70 |
A summary of the stock options exercised and tax benefits realized from stock based compensation is presented below for the three fiscal years ended (in thousands):
|  | Fiscal years ended |
|  | 2017 |  |  | 2016 |  |  | 2015 |
Total cash received |  | $ | 2,910 |  |  | $ | — |  |  | $ | 54 |
Income tax (expense) benefit |  |  | 265 |  |  |  | (46 | ) |  |  | (106 | )
Total grant-date fair value |  |  | 532 |  |  |  | — |  |  |  | 9 |
Intrinsic value |  |  | 969 |  |  |  | — |  |  |  | 36 |
A summary of the status of the Company’s unvested stock options at February 29, 2016, and changes during the fiscal year ended February 28, 2017 is presented below:
|  | Number of Options |  |  | Weighted Average Grant Date Fair Value |
Unvested at February 29, 2016 |  |  | 76,425 |  |  | $ | 2.32 |
New grants |  |  | — |  |  |  | — |
Vested |  |  | (71,352 | ) |  |  | 2.32 |
Forfeited |  |  | — |  |  |  | — |
Unvested at February 28, 2017 |  |  | 5,073 |  |  | $ | 2.41 |
As of February 28, 2017, there was $3,000 of unrecognized compensation cost related to unvested stock options granted under the Plan. The weighted average remaining requisite service period of the unvested stock options was 0.8 years. The total fair value of shares underlying the options vested during the fiscal year ended February 28, 2017 was $1.2 million. The following table summarizes information about stock options outstanding at the end of fiscal year 2017:
|  | Options Outstanding |  |  | Options Exercisable |
Exercise Prices |  | Number Outstanding |  |  | Weighted Average Remaining Contractual Life (in Years) |  |  | Weighted Average Exercise Price |  |  | Number Exercisable |  |  | Weighted Average Exercise Price |
$8.94 to $13.69 |  |  | 24,848 |  |  |  | 3.3 |  |  | $ | 9.87 |  |  |  | 21,616 |  |  | $ | 9.30 |
14.05 to 15.78 |  |  | 51,956 |  |  |  | 5.6 |  |  |  | 15.16 |  |  |  | 50,115 |  |  |  | 15.13 |
17.57 to 18.46 |  |  | 95,692 |  |  |  | 3.7 |  |  |  | 17.97 |  |  |  | 95,692 |  |  |  | 17.97 |
|  |  | 172,496 |  |  |  | 4.2 |  |  |  | 15.95 |  |  |  | 167,423 |  |  |  | 16.00 |
Restricted Stock The Company had the following restricted stock grants activity for each of the three fiscal years ended February 28, 2017:
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding at March 1, 2014 |  |  | 180,902 |  |  | $ | 15.77 |
Granted |  |  | 85,807 |  |  |  | 15.78 |
Terminated |  |  | — |  |  |  | — |
Vested |  |  | (113,061 | ) |  |  | 16.42 |
Outstanding at February 28, 2015 |  |  | 153,648 |  |  | $ | 15.30 |
Granted |  |  | 113,648 |  |  |  | 13.69 |
Terminated |  |  | — |  |  |  | — |
Vested |  |  | (77,900 | ) |  |  | 15.24 |
Outstanding at February 29, 2016 |  |  | 189,396 |  |  | $ | 14.36 |
Granted |  |  | 66,685 |  |  |  | 19.49 |
Terminated |  |  | — |  |  |  | — |
Vested |  |  | (89,535 | ) |  |  | 14.46 |
Outstanding at February 28, 2017 |  |  | 166,546 |  |  | $ | 16.35 |
As of February 28, 2017, the total remaining unrecognized compensation cost related to unvested restricted stock was approximately $1.5 million. The weighted average remaining requisite service period of the unvested restricted stock awards was 1.4 years. As of February 28, 2017, the Company’s outstanding restricted stock had an underlying fair value of $2.7 million at date of grant.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration